您当前位置:INFLAMMOPHARMACOLOGY期刊投稿发表详细信息
INFLAMMOPHARMACOLOGY

INFLAMMOPHARMACOLOGY Q1

  • 期刊收录:
  • SCIE
  • Scopus
基本信息
  • 期刊ISSN:

    0925-4692

  • 期刊简拼:

    INFLAMMOPHARMACOLOGY

  • 年发文章数:

    263

  • E-ISSN:

    1568-5608

  • Gold OA文章占比

    20.93%

  • 研究文章占比:

    65.78%

  • 是否OA:

    No

  • Jcr分区:

    Q1

  • 中科院分区:

    2区

出版信息
  • 出版商:

    Springer International Publishing

  • 涉及研究方向:

    IMMUNOLOGYTOXICOLOGY-TOXICOLOGY

  • 出版国家:

    NETHERLANDS

  • 出版语言:

    English

  • 出版周期:

    6 issues per year

  • 出版年份:

    1991

  • 2023-2024最新影响因子:4.6
  • 自引率:4.30%
  • 五年影响因子:4.5
  • JCI期刊引文指标:1.07
  • h-index:45
  • CiteScore:8.00

期刊简介

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas:

-Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress states
-Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs
-Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents
-Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain
-Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDs
-Muscle-immune interactions during inflammation [...]

《INFLAMMOPHARMACOLOGY》期刊已被查看:

此期刊被最新的JCR期刊SCIE收录

期刊信息

  • 通讯地址
  • PICASSOPLATZ 4, BASEL, SWITZERLAND, 4052
  • 中国科学院《国际期刊预警名单(试行)》名单
  • 2024年02月发布的2024版:不在预警名单中
    2023年01月发布的2023版:不在预警名单中
    2021年12月发布的2021版:不在预警名单中
    2020年12月发布的2020版:不在预警名单中
    此期刊被最新的JCR期刊SCIE收录
  • 审稿速度
  • 收录数据库
  • 是否oa
  • 研究方向
  • SCIE,Scopus
  • No
  • IMMUNOLOGYTOXICOLOGY-TOXICOLOGY

分区信息

中科院分区
  • 大类学科
  • 分区
  • 小类学科
  • Top期刊
  • 综述期刊
  • 医学
  • 2区
  • TOXICOLOGY
    毒理学
    IMMUNOLOGY
    免疫学
WOS分区等级:1区
  • 版本
  • 按学科
  • 分区
  • 影响因子
  • WOS期刊SCI分(2023-2024年最新版)
  • IMMUNOLOGY
    TOXICOLOGY
  • Q1
  • 4.6
IF值(影响因子)趋势图
年发文量趋势图
自引率趋势图
中科院分区

常见问题

INFLAMMOPHARMACOLOGY相关文章